These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 37251979)
1. A clinically viable approach to restoring visual function using optogenetic gene therapy. Yan B; Viswanathan S; Brodie SE; Deng WT; Coleman KE; Hauswirth WW; Nirenberg S Mol Ther Methods Clin Dev; 2023 Jun; 29():406-417. PubMed ID: 37251979 [TBL] [Abstract][Full Text] [Related]
2. Optogenetic approaches to vision restoration. Simunovic MP; Shen W; Lin JY; Protti DA; Lisowski L; Gillies MC Exp Eye Res; 2019 Jan; 178():15-26. PubMed ID: 30218651 [TBL] [Abstract][Full Text] [Related]
3. Restoring vision using optogenetics without being blind to the risks. Harris AR; Gilbert F Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):41-45. PubMed ID: 34724112 [TBL] [Abstract][Full Text] [Related]
6. Optogenetic Stimulation for Restoring Vision to Patients Suffering From Retinal Degenerative Diseases: Current Strategies and Future Directions. Montazeri L; El Zarif N; Trenholm S; Sawan M IEEE Trans Biomed Circuits Syst; 2019 Dec; 13(6):1792-1807. PubMed ID: 31689206 [TBL] [Abstract][Full Text] [Related]
7. Advances in Ophthalmic Optogenetics: Approaches and Applications. Prosseda PP; Tran M; Kowal T; Wang B; Sun Y Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204770 [TBL] [Abstract][Full Text] [Related]
8. Degenerated Cones in Cultured Human Retinas Can Successfully Be Optogenetically Reactivated. Kamar S; Howlett MHC; Klooster J; Graaff W; Csikós T; Rabelink MJWE; Hoeben RC; Kamermans M Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947650 [TBL] [Abstract][Full Text] [Related]
9. Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa. Conlon TJ; Deng WT; Erger K; Cossette T; Pang JJ; Ryals R; Clément N; Cleaver B; McDoom I; Boye SE; Peden MC; Sherwood MB; Abernathy CR; Alkuraya FS; Boye SL; Hauswirth WW Hum Gene Ther Clin Dev; 2013 Mar; 24(1):23-8. PubMed ID: 23692380 [TBL] [Abstract][Full Text] [Related]
10. Optogenetic approaches to therapy for inherited retinal degenerations. De Silva SR; Moore AT J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243 [TBL] [Abstract][Full Text] [Related]
11. Vision Restoration by Optogenetic Therapy and Developments Toward Sonogenetic Therapy. Provansal M; Marazova K; Sahel JA; Picaud S Transl Vis Sci Technol; 2022 Jan; 11(1):18. PubMed ID: 35024784 [TBL] [Abstract][Full Text] [Related]
12. Optogenetic Strategies for Vision Restoration. Lu Q; Pan ZH Adv Exp Med Biol; 2021; 1293():545-555. PubMed ID: 33398841 [TBL] [Abstract][Full Text] [Related]
13. Treatment of retinitis pigmentosa due to MERTK mutations by ocular subretinal injection of adeno-associated virus gene vector: results of a phase I trial. Ghazi NG; Abboud EB; Nowilaty SR; Alkuraya H; Alhommadi A; Cai H; Hou R; Deng WT; Boye SL; Almaghamsi A; Al Saikhan F; Al-Dhibi H; Birch D; Chung C; Colak D; LaVail MM; Vollrath D; Erger K; Wang W; Conlon T; Zhang K; Hauswirth W; Alkuraya FS Hum Genet; 2016 Mar; 135(3):327-43. PubMed ID: 26825853 [TBL] [Abstract][Full Text] [Related]
14. Dampening Spontaneous Activity Improves the Light Sensitivity and Spatial Acuity of Optogenetic Retinal Prosthetic Responses. Barrett JM; Hilgen G; Sernagor E Sci Rep; 2016 Sep; 6():33565. PubMed ID: 27650332 [TBL] [Abstract][Full Text] [Related]
15. Optogenetic approaches to restoring visual function in retinitis pigmentosa. Busskamp V; Roska B Curr Opin Neurobiol; 2011 Dec; 21(6):942-6. PubMed ID: 21708457 [TBL] [Abstract][Full Text] [Related]
16. Restoring vision in mice with retinal degeneration using multicharacteristic opsin. Wright W; Gajjeraman S; Batabyal S; Pradhan S; Bhattacharya S; Mahapatra V; Tripathy A; Mohanty S Neurophotonics; 2017 Oct; 4(4):041505. PubMed ID: 28948190 [TBL] [Abstract][Full Text] [Related]
17. Restoring vision in mice with retinal degeneration using multicharacteristic opsin. Wright W; Gajjeraman S; Batabyal S; Pradhan S; Bhattacharya S; Mahapatra V; Tripathy A; Mohanty S Neurophotonics; 2017 Oct; 4(4):041412. PubMed ID: 28840163 [TBL] [Abstract][Full Text] [Related]
18. An Engineering Platform for Clinical Application of Optogenetic Therapy in Retinal Degenerative Diseases. Yan B; Nirenberg S IEEE J Transl Eng Health Med; 2023; 11():296-305. PubMed ID: 37250684 [TBL] [Abstract][Full Text] [Related]
19. Strategies for expanding the operational range of channelrhodopsin in optogenetic vision. Mutter M; Münch TA PLoS One; 2013; 8(11):e81278. PubMed ID: 24312285 [TBL] [Abstract][Full Text] [Related]
20. A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision. Chemi G; Brindisi M; Brogi S; Relitti N; Butini S; Gemma S; Campiani G Future Med Chem; 2019 Mar; 11(5):463-487. PubMed ID: 30907134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]